Literature DB >> 6119764

Effect of metronidazole and sulfasalazine on the normal human faecal flora.

A Krook.   

Abstract

Nine healthy individuals were treated with metronidazole (Flagyl) for 2 weeks and sulfasalazine (Salazopyrin) for 2 further weeks or inversely after randomization. Before, at the day for cross-over, and the end of treatment, quantitative and qualitative studies of the aerobic and anaerobic faecal bacteria and plasma concentration studies of the drugs were performed. The total counts of aerobic and anaerobic bacteria were in close agreement with those reported by others. A comparison between pretreatment samples and those taken at the end of treatment showed a significant or almost significant increase in the count of faecal streptococci (P = 0.03) and of Escherichia coli (P = 0.06) in subjects treated with metronidazole, but not with sulfasalazine. However, the changes in the anaerobic bacterial flora reported during treatment in patients with Crohn's disease with the same drugs were not observed among the healthy individuals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119764     DOI: 10.3109/00365528109182016

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Effect of selective media on recovery of obligately anaerobic gram-negative rods from human faeces.

Authors:  J G Ruseler-Van Embden; H C Both-Patoir
Journal:  Antonie Van Leeuwenhoek       Date:  1983-11       Impact factor: 2.271

2.  Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora.

Authors:  Kenneth F Blount; Cynthia Megyola; Mark Plummer; David Osterman; Tim O'Connell; Paul Aristoff; Cheryl Quinn; R Alan Chrusciel; Toni J Poel; Heinrich J Schostarez; Catherine A Stewart; Daniel P Walker; Peter G M Wuts; Ronald R Breaker
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects.

Authors:  J G Ruseler-van Embden; H C Both-Patoir
Journal:  Antonie Van Leeuwenhoek       Date:  1983-06       Impact factor: 2.271

4.  Faecal bile acid excretion in children with inflammatory bowel disease.

Authors:  J Ejderhamn; J J Rafter; B Strandvik
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

5.  Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms.

Authors:  Dorothy F Newton; Sandra Macfarlane; George T Macfarlane
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

6.  Clostridium difficile and inflammatory bowel disease.

Authors:  C Greenfield; J R Aguilar Ramirez; R E Pounder; T Williams; M Danvers; S R Marper; P Noone
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

Review 7.  Pharmacological and biochemical actions of sulphasalazine.

Authors:  J R Hoult
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 8.  The human faecal flora and Crohn's disease.

Authors:  J P van de Merwe
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

Review 9.  The gut-joint axis in rheumatoid arthritis.

Authors:  Mario M Zaiss; Hsin-Jung Joyce Wu; Daniele Mauro; Georg Schett; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-03-05       Impact factor: 32.286

Review 10.  Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.

Authors:  Ting Zhao; Yuanyuan Wei; Youyang Zhu; Zhaohu Xie; Qingshan Hai; Zhaofu Li; Dongdong Qin
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.